138 related articles for article (PubMed ID: 19010227)
1. Role of osteopontin and CD44s expression for patients with hepatocellular carcinoma undergoing liver transplantation or resection.
Beckebaum S; Chen X; Sotiropoulos GC; Radtke A; Daoudaki M; Baba HA; Wohlschlaeger J; Broelsch CE; Gerken G; Cicinnati VR
Transplant Proc; 2008 Nov; 40(9):3182-4. PubMed ID: 19010227
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expressions of annexin A10 short isoform, osteopontin and alpha-fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma.
Peng SY; Ou YH; Chen WJ; Li HY; Liu SH; Pan HW; Lai PL; Jeng YM; Chen DC; Hsu HC
Int J Oncol; 2005 Apr; 26(4):1053-61. PubMed ID: 15754002
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma.
Xie H; Song J; Du R; Liu K; Wang J; Tang H; Bai F; Liang J; Lin T; Liu J; Fan D
Dig Liver Dis; 2007 Feb; 39(2):167-72. PubMed ID: 17161983
[TBL] [Abstract][Full Text] [Related]
5. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.
Ikeguchi M; Iwamoto A; Taniguchi K; Katano K; Hirooka Y
J Exp Clin Cancer Res; 2005 Sep; 24(3):415-21. PubMed ID: 16270528
[TBL] [Abstract][Full Text] [Related]
6. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof].
Shen HW; Wu YL; Peng SY
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of osteopontin expression in human gastric carcinoma.
Higashiyama M; Ito T; Tanaka E; Shimada Y
Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.
Kim J; Ki SS; Lee SD; Han CJ; Kim YC; Park SH; Cho SY; Hong YJ; Park HY; Lee M; Jung HH; Lee KH; Jeong SH
Am J Gastroenterol; 2006 Sep; 101(9):2051-9. PubMed ID: 16848813
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
[TBL] [Abstract][Full Text] [Related]
10. Analysis of alpha-fetoprotein mRNA level on the tumor cell hematogenous spread of patients with hepatocellular carcinoma undergoing orthotopic liver transplantation.
Wang YL; Li G; Wu D; Liu YW; Yao Z
Transplant Proc; 2007; 39(1):166-8. PubMed ID: 17275497
[TBL] [Abstract][Full Text] [Related]
11. Gene and protein expression of RCAS1 in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Anticancer Res; 2003; 23(6D):4967-71. PubMed ID: 14981953
[TBL] [Abstract][Full Text] [Related]
12. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
Yuan RH; Jeng YM; Chen HL; Lai PL; Pan HW; Hsieh FJ; Lin CY; Lee PH; Hsu HC
J Pathol; 2006 Aug; 209(4):549-58. PubMed ID: 16739096
[TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370
[TBL] [Abstract][Full Text] [Related]
14. [Osteopontin as a potential biomarker of metastasis and recurrence for hepatocellular carcinoma].
Cui BK; Zhang CQ; Zhang Y; Yuan YF; Zhang YQ; Shi M; Chen MS; Li SP; Li JQ
Ai Zheng; 2006 Jul; 25(7):876-9. PubMed ID: 16831281
[TBL] [Abstract][Full Text] [Related]
15. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells].
Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482
[TBL] [Abstract][Full Text] [Related]
16. Perioperative change in albumin messenger RNA levels in patients with hepatocellular carcinoma.
Gion T; Taketomi A; Shimada M; Shirabe K; Hasegawa H; Takenaka K; Sugimachi K
Hepatology; 1998 Dec; 28(6):1663-8. PubMed ID: 9828232
[TBL] [Abstract][Full Text] [Related]
17. [The prognostic significance of preoperative plasma level of osteopontin in combination with intercellular adhesion molecule-1 for patients with hepatocellular carcinoma].
Zhang H; Ren N; Ye QH; Sun HC; Wang L; Liu YK; Tang ZY; Qin LX
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):985-8. PubMed ID: 16194354
[TBL] [Abstract][Full Text] [Related]
18. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M
Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma.
Chau GY; Lee AF; Tsay SH; Ke YR; Kao HL; Wong FH; Tsou AP; Chau YP
Histopathology; 2007 Aug; 51(2):204-18. PubMed ID: 17559540
[TBL] [Abstract][Full Text] [Related]
20. [Focal adhesion kinase mRNA overexpression in hepatocellular carcinoma HCC) and correlation thereof with prognosis of HCC].
Yuan Z; Fan J; Wu ZQ; Zhou J; Qiu SJ
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1256-9. PubMed ID: 17686260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
